Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (481-490 of 616) with videos related to

Pageof 62
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|August 9, 2025
Comparison of Myocardial Mechanics Post Mitral Valve Repair with Leaflet Preservation vs. Leaflet Resection: A Sub-Analysis of the Randomized CAMRA CardioLink-2 TrialRawan K Rumman, Subodh Verma, Vincent Chan, et al.
JACC. Heart Failure|September 16, 2023
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-ReducedNitish K Dhingra, Subodh Verma, Javed Butler, et al.
Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2021
A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgeryMark D Peterson, Vinay Garg, C David Mazer, et al.
Journal of the American Heart Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-RegressionAyodele Odutayo, Bruno R da Costa, Tiago V Pereira, et al.
The Journal of Biological Chemistry|December 14, 2011
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failureKrishna K Singh, Praphulla C Shukla, Adrian Quan, et al.
Circulation. Heart Failure|August 30, 2024
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE TrialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
The Annals of Thoracic Surgery|July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized TrialMakoto Hibino, Arjun K Pandey, Vincent Chan, et al.
The Lancet. Diabetes & Endocrinology|January 23, 2025
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA<sub>1c</sub> levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trialsSubodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
Pageof 62

Showing results (481-490 of 616) with videos related to

Sort By:
Pageof 62
The Journal of Thoracic and Cardiovascular Surgery|August 9, 2025
Comparison of Myocardial Mechanics Post Mitral Valve Repair with Leaflet Preservation vs. Leaflet Resection: A Sub-Analysis of the Randomized CAMRA CardioLink-2 TrialRawan K Rumman, Subodh Verma, Vincent Chan, et al.
JACC. Heart Failure|September 16, 2023
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-ReducedNitish K Dhingra, Subodh Verma, Javed Butler, et al.
Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2021
A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgeryMark D Peterson, Vinay Garg, C David Mazer, et al.
Journal of the American Heart Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-RegressionAyodele Odutayo, Bruno R da Costa, Tiago V Pereira, et al.
The Journal of Biological Chemistry|December 14, 2011
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failureKrishna K Singh, Praphulla C Shukla, Adrian Quan, et al.
Circulation. Heart Failure|August 30, 2024
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE TrialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
The Annals of Thoracic Surgery|July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized TrialMakoto Hibino, Arjun K Pandey, Vincent Chan, et al.
The Lancet. Diabetes & Endocrinology|January 23, 2025
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA<sub>1c</sub> levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trialsSubodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
Pageof 62